Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700032110

Trial Profile

Clinical Trials Insight: 700032110

Phase of Trial: Phase I

Latest Information Update: 14 Nov 2008

At a glance

  • Drugs RDEA 436 (Primary)
  • Indications Cancer; Inflammation
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Pharmacokinetics
  • Sponsors Ardea Biosciences
  • Most Recent Events

    • 14 Nov 2008 Planned start date reported as the first quarter of 2009 by Ardea Biosciences.
    • 07 Oct 2008 Planned start date reported as the fourth quarter of 2008 by Ardea Biosciences.
    • 17 Apr 2008 The trial is expected to be initiated in the second half of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top